Association of plasma markers of cholesterol homeostasis with metabolic syndrome components. A cross-sectional study

Cofán, M.; Escurriol, V.; García-Otín, A.L.; Moreno-Iribas, C.; Larrañaga, N.; Sánchez, M.J.; Tormo, M.J.; Redondo, M.L.; González, C.A.; Corella, D.; Pocoví, M.; Civeira, F.; Ros, E.

doi:10.1016/j.numecd.2010.01.005

« Previous Next »Nutrition, Metabolism & Cardiovascular Diseases
Volume 21, Issue 9 , Pages 651-657, September 2011

Association of plasma markers of cholesterol homeostasis with metabolic syndrome components. A cross-sectional study☆

M. Cofán
- Lipid Clinic, Endocrinology and Nutrition Service, Biomedical Research Institute August Pi i Sunyer, Hospital Clínic, Barcelona, Spain
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Instituto de Salud Carlos III (ISCIII), Spain
- Corresponding author. Lipid Clinic, Endocrinology and Nutrition Service, Hospital Clínic, Villarroel 170, 08036 Barcelona, Spain. Tel.: +34 636 295 015; fax: +34 93 227 56 97.
- These authors equally contributed to this work.
V. Escurriol
- Lipid Clinic, Endocrinology and Nutrition Service, Biomedical Research Institute August Pi i Sunyer, Hospital Clínic, Barcelona, Spain
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Instituto de Salud Carlos III (ISCIII), Spain
- These authors equally contributed to this work.
A.L. García-Otín
- Lipid Unit and Molecular Biology Laboratory, Hospital Universitario Miguel Servet, Instituto Aragonés de Ciencias de la Salud, Zaragoza, Spain
C. Moreno-Iribas
- Public Health Institute of Navarra, Pamplona, Spain
- CIBER Epidemiología y Salud Pública (CIBEResp), ISCIII, Spain
- Department of Pediatrics, Obstetrics, Gynecology and Preventive Medicine, Autonoma University of Barcelona, Barcelona, Spain
N. Larrañaga
- CIBER Epidemiología y Salud Pública (CIBEResp), ISCIII, Spain
- Public Health Department of Gipuzkoa, Gipuzkoa, Spain
M.J. Sánchez
- CIBER Epidemiología y Salud Pública (CIBEResp), ISCIII, Spain
- Andalusian School of Public Health, Granada, Spain
M.J. Tormo
- CIBER Epidemiología y Salud Pública (CIBEResp), ISCIII, Spain
- Department of Epidemiology, Regional Health Council, Murcia, Spain
M.L. Redondo
- Public Health Directorate, Health and Health Care Services Council, Asturias, Spain
C.A. González
- Unit of Nutrition, Environment and Cancer, Catalan Institute of Oncology, Barcelona, Spain
- RTIC RD06/0020, ISCIII, Spain
D. Corella
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Instituto de Salud Carlos III (ISCIII), Spain
- Department of Preventive Medicine and Public Health, School of Medicine, University of Valencia, Valencia, Spain
M. Pocoví
- Departament of Biochemistry and Molecular and Cellular Biology, University of Zaragoza, Zaragoza, Spain
- CIBER de Enfermedades Raras (CIBERer), ISCIII, Spain
F. Civeira
- Lipid Unit and Molecular Biology Laboratory, Hospital Universitario Miguel Servet, Instituto Aragonés de Ciencias de la Salud, Zaragoza, Spain
- RTIC C06/01(RECAVA), ISCIII, Spain
E. Ros
- Lipid Clinic, Endocrinology and Nutrition Service, Biomedical Research Institute August Pi i Sunyer, Hospital Clínic, Barcelona, Spain
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Instituto de Salud Carlos III (ISCIII), Spain